Effects of Vitamin D3 level on the gene expression of Immune checkpoint Cytotoxic T-lymphocytes antigen-4 in Iraqi patients with rheumatoid arthritis

Aseel S. Mahmood, Ahmed Sabah Kadhim, Yasir W. Issa

Abstract


Background: Rheumatoid arthritis is chronic autoimmune inflammatory disease that affects synovium, rheumatoid arthritis. Antigen presentation cells (APCs) link B7-1 and B7-2 with cytotoxic T-lymphocyte related protein-4 (CTLA-4), the member of the immunoglobulin superfamily, that causes T-regulatory cells to cause APCs to produce an inhibitory signal to autoreactive T cells (Treg). This study looked at the effects of vitamin D3(Vit-D3) on the expression of the CTLA-4 gene in whole blood taken from RA patients.

Methods: The case control study was conducted on 100RA patients acute and remission stages of the disease depending on DAS-28 and CDAI with respect to the level of vitamin D3. The cases and samples were obtained from Baghdad Teaching Hospital, Baghdad, Iraq from Jun 2022 to January 2023. In addition,45 healthy subjects were enrolled in this study. Standardized gene expression at a level of a reference gene (GAPDH) and enumerated by the ∆Ct-value and fold change (2-∆∆Ct) method using qPCR. The ESR was measured in all subjects and serum CTLA-4, anti-cyclic citrullinated peptide (ACCP), RF was measured using ELISA techniques. The D3 level was assessed using immunofluorescent technique.

Results: Significantly increased ESR and serum CTLA-4 levels, ACCP, CRP, RF in RA patients compared to controls (p≤0.05), respectively. The vitamin D3 was significantly reduced in acute cases and substantial raised in remission case compared to the controls (p≤0.05) fold change of gene expression was dramatically elevated in patients excepts in acute male cases compared to 1. There was a significant positive correlation between vitamin D3 and CTLA-4 expression.

Conclusion: The current study showed that Vit-D3 up-regulates CTLA-4 gene expression as the defensive mechanism in contradiction of a severity of a disease and possible therapeutic targets through the action of Treg population and immunotolerance.


Full Text:

PDF

References


Guo Q, Wang Y, Xu D, Nossent J, Pavlos N and Xu J. Rheumatoid arthritis pathological mechanisms and modern pharmacologic therapies. Bone Research, (2018); 6 (15).

Biton J, Boissier M, Bessis N. TNFα Activator or inhibitor of regulatory T cells? Joint Bone Spine, (2012); 79(2): 119–123.

Tanhapour M, VaisiRaygani A, Khazaei M, Rahimi Z, Pourmotabbed T, Tanhapour M, Pourmotabbed T. Cytotoxic T-lymphocyte Associated Antigen-4 (CTLA-4) Polymorphism, Cancer, and Autoimmune

Diseases. AIMS Medical Science, (2017); 4(4): 395–412.

Alfadhli S. Overexpression and Secretion of the Soluble CTLA-4 Splice Variant in Various Autoimmune Diseases and in Cases with Overlapping Autoimmunity. Genetic Testing and Molecular Biomarkers, (2013); 17(4): 336.

Sharifi A, Vahedi H, Honarvar, M, Alipoor B, Nikniaz Z, Rafiei H, Hosseinzadeh-Attar M. Vitamin D Increases CTLA-4 Gene Expression in Patients with Mild to Moderate Ulcerative Colitis. Middle East Journal of Digestive Diseases, (2019);11(4): 199.

Lei C, Dongqing Z, Yeqing S, Oaks M, Lishan C, Jianzhong J, DaMing R. Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. European Journal of Human Genetics, (2005); 13(7): 823–828.

Sushama S, Dixit N, Gautam R, Arora P, Khurana A, Anubhuti A. Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-α) in vitiligo-New insight into pathogenesis of disease. Journal of Cosmetic Dermatology, (2019);18(1): 337–341.

Liu W, Yang Z, Chen Y, Yang H, Wan X, Zhou X, Zhang Y. The Association Between CTLA-4, CD80/86, and CD28 Gene Polymorphisms and Rheumatoid Arthritis: An Original Study and Meta-Analysis. Frontiers in Medicine, (2021); 8:598076.

Sharpe A, Freeman G. The B7-CD28 superfamily. Nature reviews. Immunology, (2002); 2(2): 116–126.

Livak K, Schmittgen T. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 C T Method. National center of biotechnology information, (2001); 25: 402–408.

Rowshanravan B, Halliday N, Sansom D. CTLA-4: a moving target in immunotherapy. National Center for Biotechnology Information, (2018); 131(1): 58–67.

Mohannad N, Nassar S, Moaaz M, Elnemr R, Sultan A. Immunological analysis of vitamin D receptor gene expression in Egyptian patients with rheumatoid arthritis: relation to disease activity and functional disability. Egyptian Rheumatology and Rehabilitation, (2020); 47:1, 47(1): 1–10.

Maller B, McVean G, Byrnes J, Vukcevic D, Palin K, Su Z, Donnelly P. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nature Genetics, (2012); 44(12): 1294–1301.

Jain N, Nguyen H, Chambers C, Kang J. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proceedings of the National Academy of Sciences, (2010); 107(4): 1524–1528.

Liu L, Chen H, Chu J, Chen H, Lai H, Sytwu K, Chang M. Interleukin (IL)-23 p19 expression induced by IL-1β in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor- κB and AP-1 dependent pathway. The National Center for Biotechnology Information advances science, (2007); 46(8): 1266–1273.

Flores-Borja F, Jury C, Mauri C, Ehrenstein R. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America, (2008); 105(49): 19396 –19401.

Stummvoll H, DiPaolo J, Huter N, Davidson S, Glass D, Ward M, Shevach M. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. Journal of immunology, (2008); 181(3): 1908–1916.

Crellin K, Garcia V, Levings K. Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood, The National Center for Biotechnology Information advances science, (2007); 109(5): 2014–2022.

Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. Journal of immunology, (2000); 164(5): 2405–2411.

Harrison R, Li D, Jeffery E, Raza K, Hewison M. Vitamin D, Autoimmune Disease and Rheumatoid Arthritis. Calcified Tissue International, (2020); 106(1): 58.

Ad’hiah A, Mahmood S, Al-Kazaz A. Mayouf K. Gene Expression and Polymorphism of Interleukin-4 in a Sample of Iraqi Rheumatoid Arthritis Patients. Baghdad Science Journal, (2018); 15(2): 130.

Mahmood S, Al-Kazaz A, Ad’hiah A. Single Nucleotide Polymorphism of IL1B Gene (rs16944) in a Sample of Rheumatoid Arthritis Iraqi Patients.Iraqi Journal of Science, (2018); 59(2C): 1041–1045.




DOI: http://dx.doi.org/10.62940/als.v10i0.2079

Refbacks

  • There are currently no refbacks.